April 17, 2013 11:29 am by Frost, Peter | 0 Comments
Abbott Laboratories, in its first quarterly earnings report without its proprietary pharmaceutical arm, said first-quarter net income from its continuing operations rose 55 percent to $544 million, or 34 cents ...
Read more